Litcius/Paper detail

Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer

Zixu Zhang, David Westover, Zhantong Tang, Yue Liu, Jinghan Sun, Yun-Xi Sun, Runqing Zhang, Xingyue Wang, Shihui Zhou, Nigaerayi Hesilaiti, Qi Xia, Zhenfang Du

2024Journal of Translational Medicine45 citationsDOIOpen Access PDF

Abstract

Wnt/β-catenin signaling is a critical pathway that influences development and therapeutic response of non-small cell lung cancer (NSCLC). In recent years, many Wnt regulators, including proteins, miRNAs, lncRNAs, and circRNAs, have been found to promote or inhibit signaling by acting on Wnt proteins, receptors, signal transducers and transcriptional effectors. The identification of these regulators and their underlying molecular mechanisms provides important implications for how to target this pathway therapeutically. In this review, we summarize recent studies of Wnt regulators in the development and therapeutic response of NSCLC.

Topics & Concepts

Wnt signaling pathwayEffectorSignal transductionBiologyCancer researchmicroRNALung cancerCancerBioinformaticsComputational biologyCell biologyMedicineGeneGeneticsOncologyCancer-related gene regulationWnt/β-catenin signaling in development and cancerRNA modifications and cancer
Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer | Litcius